menu search

Eur/gbp price analysis: remains subdued and oscillates above 0.8600 amid risk-off impulse

The EUR/GBP extended its losses to five straight trading days and hovers at around the September 28 swing low of 0.8629, amidst a risk-off impulse cou...

October 9, 2023, 11:29 pm

S&p 500 hits two-week high of $4,340 as equities shrug off gaza escalation fears

The Standard & Poor’s (S&P) 500 equity index is trading near $4,330, a two-week high for the index after markets recovered from an early Monday spat...

October 9, 2023, 10:00 pm

Middle east conflict sparks concerns over crude oil prices

Middle East Conflict Sparks Concerns Over Crude Oil Prices Crude oil prices experienced a sharp spike in the wake of a major offensive by Hamas on Isr...

October 9, 2023, 3:13 pm

Oil prices rally on fear of middle east supply disruptions

The Israel and Palestinian territories are not oil producers. But the Middle Eastern region accounts for almost a third of global supply. A wave of at...

October 9, 2023, 6:14 am

Nuvalent (nuvl) soars 36% on upbeat initial nsclc study data

Nuvalent (NUVL) surges 36% on encouraging preliminary results from the phase I dose-escalation portion ...

October 5, 2023, 12:02 pm

Artios to present initial phase 1 clinical monotherapy data for atr inhibitor art0380 in advanced solid tumors at the european society of medical oncology congress 2023

ART0380 is a highly competitive, wholly owned ATR inhibitor with broad clinical application alone or in combination for DDR deficient and high replica...

October 5, 2023, 12:00 pm

Black diamond therapeutics to present preclinical and clinical data at the aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...

October 4, 2023, 12:14 pm

Don't miss the boom: 3 machine learning stocks set to explode higher

The United States has been facing a confluence of threats that risk more turbulence. Currently, there are several potential challenges to contend with...

September 28, 2023, 6:42 am

Gm: we do have contingency plans, and will do what's best for the company, and customers:

escalation of a strike by UAW's top leadership is unnecessaryWe have now presented 5 separate economic ...

September 22, 2023, 5:27 pm

Realty income: it is not a fixed-income investment

Realty Income Corporation's year-to-date slump is a reminder that the REIT is not a risk-off investment. Although Realty Income completed high-yieldin...

September 20, 2023, 10:49 am

Harpoon therapeutics abstract for hpn217 accepted for poster presentation at the 20th international myeloma society annual meeting

SOUTH SAN FRANCISCO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company d...

September 6, 2023, 11:30 am

Chevron faces two-week total strike at australia lng projects

Workers at Chevron's Gorgon and Wheatstone liquefied natural gas (LNG) projects in Australia plan a total strike for two weeks from Sept. 14, a union ...

September 4, 2023, 9:03 pm

Glencore slips as investors seek damages over prospectus claims

Shares in Glencore PLC (LSE:GLEN) are firmly in the red after dozens of the world's biggest asset managers accused it of lying in past share prospectu...

August 31, 2023, 7:12 am

Us restricts exports of nvidia ai chips to middle east

Restrictions apply to A100 and H100 chips, in escalation of US efforts to restrict China's access to pr...

August 31, 2023, 5:47 am

Here's why one should sell canadian pacific kansas city (cp)

An escalation in operating expenses hurt Canadian Pacific Kansas City (CP)....

August 22, 2023, 8:17 pm

Perspective therapeutics announces first patient dosed in phase 1/2a dose escalation trial of vmt01 of its targeted alpha-particle therapy (tat), for treatment of mc1r-positive metastatic melanoma

First patient with MC1R–positive metastatic melanoma treated with 212Pb–VMT01 Preliminary data readout from dose ...

August 11, 2023, 12:05 pm

Perspective therapeutics reports second quarter fiscal 2023 results and recent business highlights

Phase I/2a clinical trials initiated: VMT-α-NET for neuroendocrine tumors, and VMT01 for melanoma. Preliminary results from initial cohorts expected ...

August 11, 2023, 12:00 pm

Werewolf therapeutics reports second quarter 2023 financial results and provides business update

– Phase 1/1b clinical trial for IL-2 INDUKINE™ WTX-124 progressing in patients with advanced or metastatic solid tumors; initial first-in-human cl...

August 10, 2023, 11:10 am

Caribou biosciences: positive cb-010 data leads to first half 2024 catalyst

Caribou Biosciences' results from the dose expansion portion of the phase 1 ANTLER study, using CB-010 for the treatment of patients with relapsed/ref...

July 17, 2023, 5:11 am

Biomea fusion: potential cure for diabetes, initiating with a buy

Biomea Fusion is a clinical-stage biotech company developing covalent small molecule inhibitors, with its lead asset BMF-219 showing promising initial...

July 16, 2023, 1:39 am


Search within

Pages Search Results: